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Maine Medical Center
Experience with Left
Ventricular Device
Explantation
Laura Onderko, MD, Lauren Vickerson, APRNFNP, Andrew Schwartzman, MD
Maine Medical Center, Portland, ME

Introduction

• Left ventricular assist device (LVAD) is an
implantable heart pump that helps support the
heart in patients with end stage heart failure
with reduced ejection fraction
• LVAD therapy is now approved for use as a
bridge to transplantation (BTT) and as a
destination therapy (DT) in patients who are not
candidates for heart transplantation.
• The existing literature suggests that close to
10% of patients implanted with LVAD could be
explanted for recovery, but the actual rate of
explant is significantly lower
• Need to examine the clinical course of
explanted patients to provide better guidance
for the decision to explant
• Purpose of this study was to describe the
characteristics and outcomes of patients who
underwent LVAD explantation at Maine Medical
Center

Results
Table 1: Patient Characteristics

Patients who underwent LVAD
Explantation were:
• Average age < 50 years old
• Diagnosed with a nonischemic cardiomyopathy
• Average time to diagnosis to
implant was less than 1 year
• More likely to tolerate
maximum guideline directed
medical thearpy and
complete cardiac rehab

Average
Gender
Age at LVAD
Implant

Diabetes
Mellitus

40.2 years 80% Male 26.8 kg/m2 20% (1 of 5)

Hypertension

Ventricular
Tachycardia

20% (1 of 5)

40% (2 of 5)

• Total of five patients included in the study
• All received a HeartMate II device as destination
therapy
• All were diagnosed with non-ischemic cardiomyopathy
• Diagnosed average of 6.2 months prior to implantation
• 80% were on inotropic infusions prior to explant
Table 2: Echocardiographic Evaluation prior to LVAD Implantation
LVEF
(normal: >55%)
15%
(range: 10-24)

LVIDd* (mm)

LVIDs** (mm)

58-82 (67)

52-77 (63)

*LVIDd = Left ventricular internal dimension diastolic dimension (normal male 42-58.4 mm & normal female 37.8-52.2 mm)
**LVIDs = Left ventricular internal dimension systolic dimension (normal male 25-39.8mm & female 21.6-34.8 mm)

Table 3: Echocardiographic Evaluation 3 months after LVAD Implantation

Methods

1. Retrospective observational study by manual
chart review
2. All patients who underwent LVAD explantation
at Maine Medical Center between 12/1/12 to
1/1/21
3. Collected information on Pre-LVAD
characteristics including prior medical
management, etiology of cardiomyopathy,
post-LVAD course including longitudinal changes
in heart function, and further medical
management

Average
BMI

LVEF (%)
34%
(range: 35-50)

LVIDd (mm)
48-57 (54)

• All explanted due to recovery
• Time from LVAD implant to explant ranged from 10-24
months (16 months average)
• 80% on maximum beta blocker thearpy, all were on
guideline directed medical therapy
• 80% completed cardiac rehab prior to explant
• 60% NYHA Class II heart failure symptoms & 40% NYHA
Class III heart failure symptoms

Discussion
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LVIDs (mm)
35-46 (43)

• In the literature, LVAD explant occurs in about 1-2%
of patients supported by LVADs
• Characteristics of patients who undergo successful
explant in prior studies are similar to our findings:
• Younger age
• Non-ischemic cardiomyopathy of short
duration (<1 year)

